Alnylam Pharmaceuticals Statistics
NASDAQ: ALNYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
224.53+0.12 (+0.05%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Alnylam Pharmaceuticals by the numbers
Alnylam Pharmaceuticals has a market capitalization of $30.04 billion based on 133.81M shares outstanding. Its trailing P/E ratio is 37.9, above the 5-company peer median of 28.4, and its forward P/E is 18.1. The stock trades 5.2% below its 50-day average and 25.0% below its 200-day average.
Average daily trading volume is 1.78M shares, or about $399.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALNY valuation vs. peer median
| Metric | ALNY | Peer median | Difference |
|---|---|---|---|
| Market cap | $30.04B | $23.78B | +26% |
| P/E (TTM) | 37.9 | 28.4 | +33% |
| Forward P/E | 18.1 | 15.8 | +15% |
| Avg. volume | 1.78M | 2.87M | -38% |
Peer median across 8 companies: ZTS, RPRX, ROIV, UTHR, GMAB, INSM, ONC, VTRS.
Valuation
- Market cap
- $30.04B
- P/E (TTM)
- 37.86
- Forward P/E
- 18.07
- Price / sales (latest FY)
- 8.09
- EPS (TTM)
- $5.93
- Shares outstanding
- 133.81M
Price and trading
- Previous close
- 224.41
- Open
- 222.05
- Day range
- 218.39 – 225.90
- 52-week range
- 197.81 – 495.55
- 52-week change
- -50.18%
- 50-day moving average
- 236.84
- 200-day moving average
- 299.45
- Beta
- —
- Volume
- 1.77M
- Average volume
- 1.78M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 30.04B
- Pe
- 37.86
- Forward Pe
- 18.07
- Eps
- 5.93
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 495.55
- Week52 Low
- 197.81
- Avg Volume
- 1.78M
- Shares Outstanding
- 133.81M
- Ma50
- 236.84
- Ma200
- 299.45
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -54.69%
- Pct From52w Low
- 13.51%